A phase II study of dasatinib and dexamethasone as primary therapy followed by hematopoietic cell transplantation for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia: CALGB Study 10701 (Alliance)
- Citation:
- Blood vol 128 (22) abstr 2782
- Meeting Instance:
- ASH 2016
- Year:
- 2016
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3410
- Pharmas:
- Bristol-Meyers
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Matthew J. Wieduwilt Jun Yin Meir Wetzler Geoff Uy Bayard L. Powell Jonathan Kolitz Michaela Liedtke Wendy Stock Jan H. Beumer Ryan J. Mattison Alese Halvorson Steven Devine Scott Smith Richard M. Stone Richard A. Larson
- Networks:
- IL017, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-OH007, LAPS-PA015, LAPS-WI020, NC002, NORTHWELL
- Study
- CALGB-10701
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: